{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:37:50Z","timestamp":1785523070077,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"SERB, Govt. of India","award":["SB\/SO\/HS-209\/2013"],"award-info":[{"award-number":["SB\/SO\/HS-209\/2013"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jneuroim.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T12:52:09Z","timestamp":1533300729000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Th17 pathway signatures in a large Indian cohort of Guillain Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"323","author":[{"given":"Monojit","family":"Debnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Nagappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Subbanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandarisamy","family":"Sundaravadivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinku Mani","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-8597","authenticated-orcid":false,"given":"Venkataram","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Wahatule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debprasad","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Binukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parayil Sankaran","family":"Bindu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Periyavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Umamaheswara Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun B.","family":"Taly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.08.001_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0015","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1073\/pnas.0600666103","article-title":"Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","article-title":"Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barre Syndrome","volume":"110","author":"Debnath","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barre syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0030","first-page":"5314541","article-title":"Th17 Cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015398","article-title":"Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection","volume":"5","author":"Edwards","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026229","article-title":"A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation","volume":"6","author":"Espinoza","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0055","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/IAI.00707-08","article-title":"Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2","volume":"77","author":"Friis","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0060","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jnr.20995","article-title":"pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity","volume":"84","author":"Frisullo","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma exchange\/sandoglobulin guillain-barre syndrome trial group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00707103","article-title":"Passive transfer of demyelination by experimental allergic neuritis serum","volume":"49","author":"Hahn","year":"1980","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","article-title":"Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barre syndrome","volume":"34","author":"Han","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0080","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1128\/IAI.01989-14","article-title":"Mycoplasma pneumoniae modulates STAT3-STAT6\/EGFR-FOXA2 signaling to induce overexpression of airway mucins","volume":"82","author":"Hao","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930601095148","article-title":"Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration","volume":"40","author":"Harada","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","article-title":"Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barre syndrome patients compared to controls","volume":"15","author":"Harness","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0095","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J. Immunol."},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2018.08.001_bb0100","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13099-016-0106-4","article-title":"The IL-23\/IL-22\/IL-18 axis in murine Campylobacter jejuni infection","volume":"8","author":"Heimesaat","year":"2016","journal-title":"Gut. Pathog."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0110","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/IAI.00129-12","article-title":"Campylobacter jejuni-mediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells","volume":"80","author":"Hu","year":"2012","journal-title":"Infect. Immun."},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2018.08.001_bb0115","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barre syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0130","first-page":"1","article-title":"Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barre syndrome","author":"Kharwar","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0135","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0140","doi-asserted-by":"crossref","first-page":"260473","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0145","doi-asserted-by":"crossref","first-page":"740947","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments","volume":"2014","author":"Li","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/08923973.2012.697469","article-title":"Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome","volume":"34","author":"Liang","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0155","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1096\/fj.201601147R","article-title":"PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"issue":"823\u201330","key":"10.1016\/j.jneuroim.2018.08.001_bb0160","first-page":"e1","article-title":"Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin","volume":"127","author":"Maddur","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0165","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2003.11.017","article-title":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology","volume":"110","author":"Morgan","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2008.11.053","article-title":"Epstein-Barr virus-derived EBNA2 regulates STAT3 activation","volume":"378","author":"Muromoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0185","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/s41598-018-21025-5","article-title":"IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barre Syndrome","volume":"8","author":"Peng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-2094-11-63","article-title":"Interleukin-17 impedes Schwann cell-mediated myelination","volume":"11","author":"Stettner","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0205","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.celrep.2017.05.013","article-title":"Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation","volume":"19","author":"Tripathi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/sji.12201","article-title":"Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis","volume":"80","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0215","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0220","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","article-title":"FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis","volume":"35","author":"Zhang","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2018.08.001_bb0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:06Z","timestamp":1759048386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818303011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"alternative-id":["S0165572818303011"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th17 pathway signatures in a large Indian cohort of Guillain Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}